Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:24835999  

AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling.

Jonathan G Murphy | Jennifer L Sanderson | Jessica A Gorski | John D Scott | William A Catterall | William A Sather | Mark L Dell'Acqua
Cell reports | 2014

L-type voltage-gated Ca2+ channels (LTCC) couple neuronal excitation to gene transcription. LTCC activity is elevated by the cyclic AMP (cAMP)-dependent protein kinase (PKA) and depressed by the Ca2+-dependent phosphatase calcineurin (CaN), and both enzymes are localized to the channel by A-kinase anchoring protein 79/150 (AKAP79/150). AKAP79/150 anchoring of CaN also promotes LTCC activation of transcription through dephosphorylation of the nuclear factor of activated T cells (NFAT). We report here that the basal activity of AKAP79/150-anchored PKA maintains neuronal LTCC coupling to CaN-NFAT signaling by preserving LTCC phosphorylation in opposition to anchored CaN. Genetic disruption of AKAP-PKA anchoring promoted redistribution of the kinase out of postsynaptic dendritic spines, profound decreases in LTCC phosphorylation and Ca2+ influx, and impaired NFAT movement to the nucleus and activation of transcription. Thus, LTCC-NFAT transcriptional signaling in neurons requires precise organization and balancing of PKA and CaN activities in the channel nanoenvironment, which is only made possible by AKAP79/150 scaffolding.

Pubmed ID: 24835999

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCATS NIH HHS, United States
    Id: UL1TR001082
  • Agency: NINDS NIH HHS, United States
    Id: T32 NS099042
  • Agency: NINDS NIH HHS, United States
    Id: R56 NS040701
  • Agency: NINDS NIH HHS, United States
    Id: R01NS040701
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL085372
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH080291
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL085372
  • Agency: NINDS NIH HHS, United States
    Id: P30NS048154
  • Agency: NIGMS NIH HHS, United States
    Id: R01GM48231
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH102338
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS048154
  • Agency: NIMH NIH HHS, United States
    Id: R01MH080291
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM048231
  • Agency: NIMH NIH HHS, United States
    Id: R01MH102338
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS040701
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001082

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.